NET INCOME (LOSS) PER SHARE (Details Narrative)	3 Months Ended
	Mar. 31, 2022 shares
Option Indexed to Issuer's Equity [Line Items]
Common stock equivalents	1,400,000
Antidilutive securities included from computation of earnings per share, amount	898,000
Share-Based Payment Arrangement, Option [Member]
Option Indexed to Issuer's Equity [Line Items]
Options to purchase of common stock	3,200,000